Coulter Partners, the global expert building leadership teams for Health, Science and Technology innovation businesses, ...

"We're thrilled to partner with ONCare to create a program focused on generating impactful -omics data that will accelerate biomarker discovery for high-need patient populations," said Ed Stepanski, ...

Ovation launches a GLP-1 dataset with WGS enabling biomaker discovery to advance precision medicine in metabolic diseases.

This dynamic field has seen tremendous change in recent years. Leaders share their perspectives on what trends we can expect ...

For modern biotherapeutics, cell line development workflows must include more than just automated liquid handling.

Lead antituberculosis (anti-TB) molecules with novel mechanisms of action are urgently required to fuel the anti-TB drug discovery pipeline. Whole-cell phenotypic screening has been employed to ...

Researchers at the University of Oklahoma have developed a breakthrough method of adding a single nitrogen atom to molecules, ...

The deal expands a deal to discover and develop treatments for obesity, type 2 diabetes and cardiovascular disease using ...

The $20 million deal gives the chip supplier a toehold in the life-sciences market, a strategy it plans to replicate in other industries.

Advanced Micro Devices Inc. is going head-to-head with bigger rival Nvidia Corp. in artificial intelligence-backed drug discovery with news of a new partnership and investment in startup Absci ...

Among the hundreds of thousands of chemical compounds produced by plants, some may hold the key to treating human ailments and diseases. But recreating these complex, naturally occurring molecules in ...

With this model, researchers may be able to discover antibody drugs capable of targeting a wide range of infectious diseases.